Virginie Collas-Aubert

Virginie Collas-Aubert has extensive experience in regulatory affairs and quality insurance within the pharmaceutical industry. Currently, as Senior Director of Regulatory Affairs at Gilead Sciences since November 2017, Virginie oversees a team of eight in managing regulatory and quality assurance activities. Prior to this role, Virginie served as International Regulatory Affairs Director at Vertex Pharmaceuticals, focusing on regulatory compliance for orphan drug launches in rare diseases. Virginie's career includes significant positions at Genzyme, where responsibilities encompassed quality and compliance direction, and Teva Pharmaceuticals, where Virginie held various roles, including Director of Product Portfolio Development and Regulatory-Economic Affairs, managing teams of up to 42 people and achieving numerous regulatory submissions and product launches. Virginie holds a Doctorate in Pharmacy and a Certificate in Healthcare Compliance Ethics & Regulation from Sciences Po.